Recent

% | $
Quotes you view appear here for quick access.

Vertex Pharmaceuticals Incorporated Message Board

ajitmd2000 2 posts  |  Last Activity: Apr 26, 2016 10:00 PM Member since: Dec 29, 2003
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    15.99$ AH

    by theanalyst88 Apr 26, 2016 5:03 PM
    ajitmd2000 ajitmd2000 Apr 26, 2016 10:00 PM Flag

    This stock has limited upside. May be $25. Drug has limited market. Long term it is going to be CAR-T.

  • ajitmd2000 ajitmd2000 Apr 25, 2016 2:50 PM Flag

    Not an expert in this area, but my impression is that CAR-T trials show remission rates to be much higher that anything I have seen even with the unintended consequences. More studies will be required, but at some point FDA will approve it. The mortality of these malignancies are quite hi with the current standard of care. Don't see the FDA seeking a hi hurdle at least for some of the hi failure cases.

    I am long CPXX, but not JUNO. I think the probabilities of early approval for VYXEOS is hi and sooner than later give the urgent need. Market cap at $575M so the risk reward/risk is ok, though I bought the stock after the big jump. Surprised the company has not been bought soon after the recent trial results were announced.

VRTX
93.89+0.68(+0.73%)Jul 22 4:00 PMEDT